TAK
TAKEDA PHARMACEUTICAL CO LTD
Latest Form 4:Sale$363KbyPlump Andrew Stewart (President, R&D) · filed Aug 21, 2026
TAKEDA PHARMACEUTICAL CO LTD (TAK) has 50 SEC Form 4 filings (53 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Aug 21, 2026.
Insiders have net sold $10.3M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Julie So-Young Kim
- Employees:47,029
- HQ:Tokyo, OS, JP
- IPO:2010-01-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10.3M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| President, R&D | Sale | 19,651 | $363K | Aug 21 | SEC ↗ | |
| Chief Human Resources Officer | Sale | 12,980 | $235K | Aug 19 | SEC ↗ | |
Farajallah Awny Samaan BotrosFirst filing | Chief Medical Officer | Sale | 14,006 | $240K | Aug 13 | SEC ↗ |
Ibrahim Ramy Riad AhmedFirst filing | President, PDT BU | Sale | 7,277 | $124K | Aug 13 | SEC ↗ |
Pacheco Rhonda JaniceFirst filing | President, U.S. Business Unit | Sale | 16,901 | $289K | Aug 13 | SEC ↗ |
Duprey Lauren RusckowskiFirst filing | Chief Transformation Officer | Sale | 47,586 | $814K | Aug 13 | SEC ↗ |
Plump Andrew StewartFirst filing | President, R&D | Sale | 165,393 | $2.8M | Aug 13 | SEC ↗ |
Pignagnoli Agosti MarcelloFirst filing | Head, Strat. & Port. Dev | Sale | 22,957 | $393K | Aug 13 | SEC ↗ |
Bitetti Teresa MarieFirst filing | President, OBU | Sale | 50,012 | $855K | Aug 13 | SEC ↗ |
| Pres., Global Supply & Quality | Sale | 3,978 | $68K | Aug 13 | SEC ↗ | |
Ricci GabrieleFirst filing | Chief Data & Tech. Officer | Sale | 25,088 | $429K | Aug 13 | SEC ↗ |
| Chief Human Resources Officer | Sale | 41,377 | $722K | Aug 13 | SEC ↗ | |
Kim Julie So-YoungFirst filing | President and CEO | Sale | 89,090 | $1.5M | Aug 13 | SEC ↗ |
Platford Giles RichardFirst filing | President, IBU | Sale | 31,083 | $532K | Aug 13 | SEC ↗ |
Furney Natalie Anne MarieFirst filing | Global General Counsel | Sale | 30,868 | $528K | Aug 13 | SEC ↗ |
Shannon Elaine MaryFirst filing | Pres., Global Supply & Quality | Sale | 20,363 | $357K | Aug 12 | SEC ↗ |
Related companies
TAKEDA PHARMACEUTICAL CO LTD is in the Healthcare sector.